Home
>
National Drug Code (NDC)
>
Zortress
Zortress - 0078-0415-20 - (everolimus)
Drug Information of Zortress
| Product NDC: | 0078-0415 |
| Proprietary Name: | Zortress |
| Non Proprietary Name: | everolimus |
| Active Ingredient(s): | .75 mg/1 & nbsp; everolimus |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zortress
| Product NDC: | 0078-0415 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021560 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100422 |
Package Information of Zortress
| Package NDC: | 0078-0415-20 |
| Package Description: | 60 BLISTER PACK in 1 BOX (0078-0415-20) > 1 TABLET in 1 BLISTER PACK (0078-0415-61) |
NDC Information of Zortress
| NDC Code | 0078-0415-20 |
| Proprietary Name | Zortress |
| Package Description | 60 BLISTER PACK in 1 BOX (0078-0415-20) > 1 TABLET in 1 BLISTER PACK (0078-0415-61) |
| Product NDC | 0078-0415 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | everolimus |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100422 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | EVEROLIMUS |
| Strength Number | .75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
